Literature DB >> 2959782

Abnormalities of cellular immunity and natural killer cells in Gaucher's disease.

Y Burstein1, V Zakuth, G Rechavi, Z Spirer.   

Abstract

Gaucher's disease (GD) which is a congenital defect characterized by the accumulation of glucocerebroside in cells of the reticulo endothelial system, is associated with malignancies of the lymphoid system such as multiple myeloma, chronic lymphatic leukemia, as well as acute leukemia of childhood. We report the immunological profile of the T-cell system in GD patients and in GD carriers. We found a variable response to lectins stimulation (PHA, Con A, PWM in various concentrations) which supports the hypothesis that a persistent antigenic stimulation in GD affects all components of the immune system of those patients. A highly significant decrease in the number of NK cells was also found, which might be a predisposing factor to the increase in malignant B and other lymphoid cell proliferations described in patients with GD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959782

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  14 in total

1.  Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype.

Authors:  Sarah M Lo; Philip Stein; Sean Mullaly; Michael Bar; Dhanpat Jain; Gregory M Pastores; Pramod K Mistry
Journal:  Am J Hematol       Date:  2010-05       Impact factor: 10.047

2.  The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.

Authors:  Tamar H Taddei; Katherine A Kacena; Mei Yang; Ruhua Yang; Advitya Malhotra; Michael Boxer; Kirk A Aleck; Gadi Rennert; Gregory M Pastores; Pramod K Mistry
Journal:  Am J Hematol       Date:  2009-04       Impact factor: 10.047

Review 3.  Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?

Authors:  Jacqueline A Hawkins-Salsbury; Adarsh S Reddy; Mark S Sands
Journal:  Hum Mol Genet       Date:  2011-03-19       Impact factor: 6.150

4.  Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.

Authors:  Sarah M Lo; Murim Choi; Jun Liu; Dhanpat Jain; Rolf G Boot; Wouter W Kallemeijn; Johannes M F G Aerts; Farzana Pashankar; Gary M Kupfer; Shrikant Mane; Richard P Lifton; Pramod K Mistry
Journal:  Blood       Date:  2012-04-04       Impact factor: 22.113

Review 5.  GBA1 and The Immune System: A Potential Role in Parkinson's Disease?

Authors:  Zaid A M Al-Azzawi; Saman Arfaie; Ziv Gan-Or
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

6.  Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease.

Authors:  Christos Sotiropoulos; George Theodorou; Constantina Repa; Theodoros Marinakis; Eugenia Verigou; Elena Solomou; Marina Karakantza; Argiris Symeonidis
Journal:  JIMD Rep       Date:  2014-10-12

7.  Leukocyte perturbation associated with Fabry disease.

Authors:  P Rozenfeld; E Agriello; N De Francesco; P Martinez; C Fossati
Journal:  J Inherit Metab Dis       Date:  2009-03-07       Impact factor: 4.982

Review 8.  Immunological cells and functions in Gaucher disease.

Authors:  Manoj Kumar Pandey; Gregory A Grabowski
Journal:  Crit Rev Oncog       Date:  2013

9.  Dendritic cells and monocyte subsets in children with Gaucher disease.

Authors:  Asmaa M Zahran; Khaled Saad; Alam-Eldin M Abdallah; Eman F Gad; Yasser F Abdel-Raheem; Zeinab Albadry M Zahran; Eman M Nagiub Abdelsalam; Amira Elhoufey; Thamer Alruwaili; Khaled Hashim Mahmoud; Khalid I Elsayh
Journal:  Pediatr Res       Date:  2021-01-19       Impact factor: 3.756

10.  Gaucher disease and cancer: concept and controversy.

Authors:  Francis Y M Choy; Tessa N Campbell
Journal:  Int J Cell Biol       Date:  2011-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.